CN1125107A - Naoyujing medicine for curing traumatic intracranial hematoma - Google Patents
Naoyujing medicine for curing traumatic intracranial hematoma Download PDFInfo
- Publication number
- CN1125107A CN1125107A CN 94113197 CN94113197A CN1125107A CN 1125107 A CN1125107 A CN 1125107A CN 94113197 CN94113197 CN 94113197 CN 94113197 A CN94113197 A CN 94113197A CN 1125107 A CN1125107 A CN 1125107A
- Authority
- CN
- China
- Prior art keywords
- rhizoma
- naoyujing
- radix
- medicine
- intracranial hematoma
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The present invention relates to a proprietary Chinese medicine-Naoyujing for curing traumatic intracranial hematoma. Said proprietary Chinese medicine-Naoyujing is made up by using the Chinese medicines with the functions of supplementing qi and activating blood circulation by removing blood stasis, promoting blood clot dissolution and removing hematoma. ADVANTAGE-. Said product is low in cost, easy to take and has no toxic side-effect.
Description
The invention belongs to a kind of Naoyujing medicine for the treatment of traumatic intracranial hematoma of pharmaceuticals industry.
Traumatic intracranial hematoma accounts for about 10% in closed trauma of head, in Heavy craniocerebral injury, account for 40-50%, it is generally acknowledged that act last hematoma surpasses the 20-30 milliliter, curtain hematoma 10 milliliters down can produce symptom and need operation, conventional viewpoint: operation is the unique method of the acute intracranial hematoma of treatment.Do not having mainly to rely on mind before the CT, the variation of pupil determines whether operation.Occur having the patient of manifest symptom all to give operative treatment more than 20 milliliters to quantity of hematoma after the CT.Opening cranium removing hematoma is a bigger damage to patient, normal easy concurrent intracranial infection, brain abscess, osteomyelitis of cranium etc.Its sequela has: hemiplegia, aphasia, traumatic epilepsy, long-term stupor, defect of skull (needing operative repair once more), mental disorder, give patient's work, life, nursing bring serious social concern, bring very big burden for country, family and individual, and the danger of recurring hematoma in addition after the operation.So China and foreign countries' neurosurgeon is all for avoid the operative treatment effort as far as possible.
Adopting the visible in recent years minority report of western medicine intracranial hematoma, mainly is the mannitol dehydration therapy.This Therapeutic Method, dewatering time is long, dosage is big, and patient's body is disturbed greatly, particularly occurs the Water-Electrolyte disorder easily.The absorption of hematoma time is longer.Ningbo City's second hospital's neurosurgery is reported one group of 200 main intracranial hematoma patient's (" Zhejiang medical science " the 9th phase in 1992) who uses mannitol dehydration and dexamethasone treatment of example can support contrast.Transfer 5 examples of performing the operation in 200 examples.Develop into brain abscess 1 example, 7 examples of leaving hospital automatically because of prognosis is bad, dead 5 examples.CT check hematoma basic absorption has 56.1% in January, and checking in addition in March, 14.4% hematoma does not absorb.
The objective of the invention is to avoid above-described weak point, and provide a kind of dissolving of removing hematoma, promoting clot that has, a kind of Naoyujing medicine for the treatment of traumatic intracranial hematoma of effects such as absorption.
Compound method of the present invention: one, at first we select the product of benefiting qi and removing blood stasis for use, play the Chinese medicine batching of the merit of dissipation hematoma altogether, press the Radix Astragali 16~28%, Radix Codonopsis 4.0~7.0%, Rhizoma Chuanxiong 4.0~7.0%, the Rhizoma Atractylodis Macrocephalae 4.0~7.0%, Poria 4.0~7.0%, Radix Angelicae Sinensis 4.0~7.0%, the Radix Rehmanniae 4.0~7.0%, Typhonium flagelliforme (Lodd.) Blume 3.0~5.0%, Semen Persicae 3.5~7.0%, Flos Carthami 3.5~7.0%, Rhizoma Corydalis 3.5~7.0%, Pericarpium Citri Reticulatae 3.5~7.0%, Rhizoma Pinelliae Preparata 3.0~5.0%, Rhizoma Cimicifugae 2.5~3.5%, Radix Glycyrrhizae 2.5~3.5%, ratio is assorted; Two, pulverize: will assort Chinese medicine mixing pulverizing is No. 1 coarser powder; Three, boil and carry: get assort in the medicinal lifting manipulation of boiling get and carry three times, add 8 times of amounts of water for the first time, boiled 2 hours, second and third time adds 6 times of amounts of water, boils 1 hour.Three medicinal liquids of leaching are concentrated into about 8000ML; Be concentrated into 1: 1~2 concentration; Four, fill: get supernatant and bottle while hot.1 material of adding medicine to, dress 200ML, 40 bottles; Five, sterilization: the bottling rear pressing cover, the circulation steam sterilization got final product in 30 minutes.Utilize above Chinese medicine preparation can treat traumatic headache, the interior blood stasis symptom of postcerebral injury syndrome and human body etc.
Major advantage of the present invention: 1.Utilize Naoyujing medicine treatment traumatic intracranial hematoma simple and easy to do, the patient is easy to accept, and is without any side effects, can make about 1/3 traumatic intracranial hematoma patient exempt operation of opening cranium and the misery of the operation of holing, and saved the outer reason expense of surgery cost and postoperative; 2, Chinese medicine is also relatively more cheap, and each patient can save hospitalization cost, and preparation is simple, takes medicine conveniently, has the removing hematoma, promotes the dissolving of clot, the function of absorption; 3, it is sick that Naoyujing medicine also can be used for treating traumatic head, blood stasis symptom in postcerebral injury syndrome and the human body.
Most preferred embodiment of the present invention: get the Radix Astragali 24.8%, Radix Codonopsis 6.2%, Rhizoma Chuanxiong 6.2%, the Rhizoma Atractylodis Macrocephalae 6.2%, Poria 6.2%, Radix Angelicae Sinensis 6.2%, the Radix Rehmanniae 6.2%, Typhonium flagelliforme (Lodd.) Blume 4.1%, Semen Persicae 6.2%, Flos Carthami 6.2%, Rhizoma Corydalis 6.2%, Pericarpium Citri Reticulatae 6.2%, Rhizoma Pinelliae Preparata 4.1%, Rhizoma Cimicifugae 2.5%, the Chinese medicine ratio preparation of Radix Glycyrrhizae 2.5%, and by pulverizing, boil and propose the technology acquisition, boil and extract three times, add 8 times of amounts of water for the first time, boiled 2 hours, second and third time respectively adds 6 times of amounts of water, boiled 1 hour, three medicinal liquids of leaching are concentrated into 8000ML, are concentrated into 1: 1.65 concentration and get final product.
Claims (3)
1, a kind of Naoyujing medicine for the treatment of traumatic intracranial hematoma, it is mainly by the Radix Astragali, Radix Codonopsis, Rhizoma Chuanxiong, the Rhizoma Atractylodis Macrocephalae, Poria, Radix Angelicae Sinensis, the Radix Rehmanniae, Typhonium flagelliforme (Lodd.) Blume, Semen Persicae, Flos Carthami, Rhizoma Corydalis, Pericarpium Citri Reticulatae, Rhizoma Pinelliae Preparata, Rhizoma Cimicifugae, Chinese medicine of licorice root is prepared from, and the liquor strength during technology is boiled and carried is 8000ML, is concentrated into 1: 1~2 concentration.
2,, it is characterized in that it is the Radix Astragali 16~28% that Chinese medicine prepares ratio, Radix Codonopsis 4.0~7.0% according to right 1 described a kind of Naoyujing medicine for the treatment of traumatic intracranial hematoma, Rhizoma Chuanxiong 4.0~7.0%, the Rhizoma Atractylodis Macrocephalae 4.0~7.0%, Poria 4.0~7.0%, Radix Angelicae Sinensis 4.0~7.0%, the Radix Rehmanniae 4.0~7.0%, Typhonium flagelliforme (Lodd.) Blume 3.0~5.0%, Semen Persicae 3.5~7.0%, Flos Carthami 3.5~7.0%, Rhizoma Corydalis 3.5~7.0%, Pericarpium Citri Reticulatae 3.5~7.0%, Rhizoma Pinelliae Preparata 3.0~5.0%, Rhizoma Cimicifugae 2.5~3.5%, Radix Glycyrrhizae 2.5~3.5%.
3,, it is characterized in that the Naoyujing medicine of Chinese medicine preparation also can be treated traumatic headache, blood stasis symptom in postcerebral injury syndrome and the human body according to claim 1,2 described a kind of Naoyujing medicines for the treatment of traumatic intracranial hematoma.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 94113197 CN1125107A (en) | 1994-12-22 | 1994-12-22 | Naoyujing medicine for curing traumatic intracranial hematoma |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 94113197 CN1125107A (en) | 1994-12-22 | 1994-12-22 | Naoyujing medicine for curing traumatic intracranial hematoma |
Publications (1)
Publication Number | Publication Date |
---|---|
CN1125107A true CN1125107A (en) | 1996-06-26 |
Family
ID=5036621
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 94113197 Pending CN1125107A (en) | 1994-12-22 | 1994-12-22 | Naoyujing medicine for curing traumatic intracranial hematoma |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1125107A (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN100446791C (en) * | 2004-10-09 | 2008-12-31 | 中国人民解放军第三军医大学第一附属医院 | Chinese medicinal composition for treating hemorrhagic brain contusion and laceration |
CN100591352C (en) * | 2009-03-03 | 2010-02-24 | 沙松华 | Traditional Chinese medicine for treating nerve function coloboma due to injury of brain and brain surgery and its preparation method |
CN101474022B (en) * | 2009-01-13 | 2010-08-25 | 赵青菊 | External-use Chinese medicine refreshment pillow for treating coma patient with brain trauma |
CN102397392A (en) * | 2011-11-10 | 2012-04-04 | 许学猛 | Stasis scattering capsules for treating traumatic injury |
-
1994
- 1994-12-22 CN CN 94113197 patent/CN1125107A/en active Pending
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN100446791C (en) * | 2004-10-09 | 2008-12-31 | 中国人民解放军第三军医大学第一附属医院 | Chinese medicinal composition for treating hemorrhagic brain contusion and laceration |
CN101474022B (en) * | 2009-01-13 | 2010-08-25 | 赵青菊 | External-use Chinese medicine refreshment pillow for treating coma patient with brain trauma |
CN100591352C (en) * | 2009-03-03 | 2010-02-24 | 沙松华 | Traditional Chinese medicine for treating nerve function coloboma due to injury of brain and brain surgery and its preparation method |
CN102397392A (en) * | 2011-11-10 | 2012-04-04 | 许学猛 | Stasis scattering capsules for treating traumatic injury |
CN102397392B (en) * | 2011-11-10 | 2014-04-09 | 许学猛 | Stasis scattering capsules for treating traumatic injury |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1840128A (en) | Medicine for treating cardiovascular disease | |
CN111920924B (en) | Traditional Chinese medicine composition for reducing uric acid and preparation method thereof | |
CN1125107A (en) | Naoyujing medicine for curing traumatic intracranial hematoma | |
CN101390993B (en) | Traditional Chinese medicine for treating diabetic foot | |
CN1110576A (en) | Rheumatism medicinal liquor and its preparation method | |
CN113730492A (en) | External medicinal liquor and using method thereof | |
CN102284053A (en) | Foot bathing preparation for treating insomnia | |
CN1814218A (en) | Hormone external-dressing agent for treating dermatitis | |
CN100382833C (en) | Mastosis treating Chinese medicine | |
CN1098001A (en) | Vision is bright | |
CN107519370B (en) | Compound preparation for treating non-allergic purpura caused by deficiency of spleen and kidney and preparation method thereof | |
CN102058813B (en) | Health protection pill for nourishing kidney and spleen and preventing yang deficiency and preparation method thereof | |
CN1615922A (en) | Chinese herbal medicine preparation for treating aplastic anemia | |
CN101085185A (en) | Beverage containing white peony root and gardenia | |
CN1358512A (en) | Gallbladder normalizing soup | |
CN1207909A (en) | Oral liquid for curing cancer | |
CN1115162C (en) | Pure traditional Chinese medicine for treating hyperosteogeny and preparation process thereof | |
CN1315187A (en) | Compound and liquid for relieving inflammation and pain | |
CN103893466A (en) | Chinese patent medicine for treating coronary heart disease and preparation method thereof | |
CN103505531A (en) | Traditional Chinese medicine formula for preventing and treating spondylodynia | |
CN1312116A (en) | Liufukang oral liquid for supporting chemotherapy and radiotherapy of terminal cancer and its preparation method | |
CN104826043A (en) | Chinese medicinal formula for treating crural sprain | |
CN100348253C (en) | Chinese medicine for treating headache resulted from function pathology | |
CN112843201A (en) | Anti-depression mixture and preparation method thereof | |
CN114699353A (en) | Bath composition and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C01 | Deemed withdrawal of patent application (patent law 1993) | ||
WD01 | Invention patent application deemed withdrawn after publication |